The Alcohol & Drug Abuse Institute

Prescription Opioid Misuse in a Large HMO

Licit and illicit use of prescription opioids, as well as associated morbidity and mortality, have increased significantly in the past six years in Washington State and nationally. Prescription opioid misuse is a constellation of behaviors characterized by unstable or chaotic patterns of medication use and aberrant patterns of medical care seeking. The biopsychosocial model will be used to examine the transition from opioid use to opioid misuse in the context of chronic pain treatment with opioids from the perspectives of health systems and clinicians.

  1. The specific aims of this proposal are to:
    Determine the prevalence of prescription opioid misuse, abuse and dependence among those prescribed chronic opioids for non-malignant pain, and to determine the correlation between opioid misuse and the commonly used diagnostic categories of opioid abuse and dependence.
  2. Model the utility of automated medical record data in differentiating between opioid misusers and non-misusers and determine the screening properties of the derived model (e.g. sensitivity, specificity, positive and negative predictive values, likelihood ratio).
  3. Assess the utility of the automated data model obtained in Aim #2, enhanced with brief interview items related to pain severity, substance abuse, and mental health symptoms to identify potential opioid misusers.

Investigators

Caleb Banta-Green, PhD, MPH, MSW PI (UW ADAI)
Donald Calsyn, PhD Original PI (UW ADAI)

Fund Information

National Institute on Drug Abuse (NIDA)
Grant #:
Start: June 10, 2006
End: May 31, 2008
Status: completed